{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:01:36Z","timestamp":1791576096595,"version":"4.3.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AstraZeneca."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189060","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T18:26:59Z","timestamp":1512498419000},"page":"e0189060","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1"],"prefix":"10.1371","volume":"12","author":[{"given":"Linda","family":"Sundstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Myhre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ahnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"McCoull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Raubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam D.","family":"Groombridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Polla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christin","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Kristensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"N\u00e5g\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-4858","authenticated-orcid":true,"given":"Maria S\u00f6rhede","family":"Winzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"issue":"9491","key":"ref1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"Group IDFETFC. The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"KG Alberti","year":"2005","journal-title":"Lancet (London, England)"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids","volume":"37","author":"G Boden","year":"2008","journal-title":"Endocrinology and metabolism clinics of North America"},{"issue":"28","key":"ref3","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.M301403200","article-title":"Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation","volume":"278","author":"E Le Poul","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"A Hirasawa","year":"2005","journal-title":"Nature medicine"},{"issue":"45","key":"ref5","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M608019200","article-title":"Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84","volume":"281","author":"J Wang","year":"2006","journal-title":"The Journal of biological chemistry"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0014-5793(03)01196-7","article-title":"Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives","volume":"554","author":"R Fredriksson","year":"2003","journal-title":"FEBS letters"},{"issue":"47","key":"ref7","doi-asserted-by":"crossref","first-page":"32913","DOI":"10.1074\/jbc.M805601200","article-title":"Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids","volume":"283","author":"LA Stoddart","year":"2008","journal-title":"The Journal of biological chemistry"},{"issue":"7389","key":"ref8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature10798","article-title":"Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human","volume":"483","author":"A Ichimura","year":"2012","journal-title":"Nature"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"DY Oh","year":"2010","journal-title":"Cell"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bcp.2013.12.016","article-title":"Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr(3)(4)(7), Ser(3)(5)(0), and Ser(3)(5)(7) in the C-terminal tail","volume":"87","author":"RN Burns","year":"2014","journal-title":"Biochemical pharmacology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-12-386933-3.00007-8","article-title":"Free fatty acid receptor GPR120 and pathogenesis of obesity and type 2 diabetes mellitus","volume":"114","author":"XL Mo","year":"2013","journal-title":"Progress in molecular biology and translational science"},{"issue":"Suppl 4","key":"ref12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1463-1326.2009.01114.x","article-title":"Lipid receptors and islet function: therapeutic implications?","volume":"11","author":"MA Kebede","year":"2009","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"ref13","first-page":"402","article-title":"The potential role of glucagon-like peptide 1 in diabetes","volume":"5","author":"JJ Meier","year":"2004","journal-title":"Current opinion in investigational drugs (London, England: 2000)"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1358\/dnp.2003.16.7.829353","article-title":"Incretins and their analogues as new antidiabetic drugs","volume":"16","author":"MA Nauck","year":"2003","journal-title":"Drug news & perspectives"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/dom.12591","article-title":"Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"18","author":"M Nauck","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/mol.113.087783","article-title":"The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism","volume":"84","author":"BD Hudson","year":"2013","journal-title":"Molecular pharmacology"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"e88227","DOI":"10.1371\/journal.pone.0088227","article-title":"Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion","volume":"9","author":"SJ Paulsen","year":"2014","journal-title":"PloS one"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.108.00802","article-title":"International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions","volume":"60","author":"LA Stoddart","year":"2008","journal-title":"Pharmacological reviews"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fendo.2011.00112","article-title":"Drug discovery opportunities and challenges at g protein coupled receptors for long chain free Fatty acids","volume":"2","author":"ND Holliday","year":"2012","journal-title":"Frontiers in endocrinology"},{"key":"ref20","unstructured":"Ma J, Novack A, Nashashibi I, Pharm P, Rabbat CJ, and Chen X, inventors; WO 2010\/048207, assignee. Aryl GPR120 receptor agonist and uses thereof. International patent WO 2020\/048207. 2010."},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nbt.1671","article-title":"Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements","volume":"28","author":"R Schroder","year":"2010","journal-title":"Nature biotechnology"},{"key":"ref22","first-page":"1","article-title":"Characterization of UBO-QIC as a Galpha inhibitor in platelets","volume":"2015","author":"V Inamdar","journal-title":"Platelets"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"e114942","DOI":"10.1371\/journal.pone.0114942","article-title":"The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120","volume":"9","author":"M Bjursell","year":"2014","journal-title":"PloS one"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejps.2014.11.006","article-title":"Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples","volume":"67","author":"J Gabrielsson","year":"2015","journal-title":"European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/mol.111.077388","article-title":"Differential signaling by splice variants of the human free fatty acid receptor GPR120","volume":"81","author":"SJ Watson","year":"2012","journal-title":"Molecular pharmacology"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00125-014-3213-0","article-title":"GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans","volume":"57","author":"VM Stone","year":"2014","journal-title":"Diabetologia"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/pr.108.000604","article-title":"The role of incretins in glucose homeostasis and diabetes treatment","volume":"60","author":"W Kim","year":"2008","journal-title":"Pharmacological reviews"},{"issue":"Pt B","key":"ref28","first-page":"160","article-title":"FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies","volume":"763","author":"HD Liu","year":"2015","journal-title":"European journal of pharmacology"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1871530316666151123115611","article-title":"GPR 120: The Potential Target for Obesity Treatment","volume":"16","author":"PA Tanagho","year":"2016","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bmcl.2017.01.034","article-title":"Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist","volume":"27","author":"SM Sparks","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/acsmedchemlett.6b00394","article-title":"Discovery of Chromane Propionic Acid Analogues as Selective Agonists of GPR120 with in Vivo Activity in Rodents","volume":"8","author":"GL Adams","year":"2017","journal-title":"ACS Med Chem Lett"},{"issue":"19","key":"ref32","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1021\/acs.jmedchem.6b00685","article-title":"Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity","volume":"59","author":"CM Azevedo","year":"2016","journal-title":"J Med Chem"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/acsmedchemlett.6b00360","article-title":"Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists","volume":"8","author":"JM Cox","year":"2017","journal-title":"ACS Med Chem Lett"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm.3614","article-title":"A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice","volume":"20","author":"Y Oh da","year":"2014","journal-title":"Nature medicine"},{"issue":"22","key":"ref35","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1074\/jbc.M114.568683","article-title":"Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion","volume":"289","author":"AT Suckow","year":"2014","journal-title":"The Journal of biological chemistry"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0706770","article-title":"Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules","volume":"148","author":"CP Briscoe","year":"2006","journal-title":"British journal of pharmacology"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/mol.110.066324","article-title":"Structure-activity relationships of GPR120 agonists based on a docking simulation","volume":"78","author":"Q Sun","year":"2010","journal-title":"Molecular pharmacology"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1021\/jm300215x","article-title":"Discovery of a potent and selective GPR120 agonist","volume":"55","author":"B Shimpukade","year":"2012","journal-title":"Journal of medicinal chemistry"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/dom.12330","article-title":"Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic beta-cells","volume":"16","author":"BM Moran","year":"2014","journal-title":"Diabetes, obesity & metabolism"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajpath.2014.09.010","article-title":"Tumor necrosis factor alpha decreases glucagon-like peptide-2 expression by up-regulating G-protein-coupled receptor 120 in Crohn disease","volume":"185","author":"T Tsukahara","year":"2015","journal-title":"The American journal of pathology"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2014.10.002","article-title":"GPR40 (FFAR1)\u2014Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo","volume":"4","author":"M Hauge","year":"2014","journal-title":"Molecular metabolism"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.molmet.2013.08.006","article-title":"Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells","volume":"2","author":"MS Engelstoft","year":"2013","journal-title":"Molecular metabolism"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"C612","DOI":"10.1152\/ajpcell.00123.2015","article-title":"A novel anti-inflammatory role of GPR120 in intestinal epithelial cells","volume":"310","author":"AN Anbazhagan","year":"2016","journal-title":"American journal of physiologyCell physiology"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/mol.115.101949","article-title":"Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4\/G Protein-Coupled Receptor 120","volume":"89","author":"R Prihandoko","year":"2016","journal-title":"Molecular pharmacology"},{"issue":"18","key":"ref45","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.4155\/fmc.15.160","article-title":"Discovery of novel FFA4 (GPR120) receptor agonists with beta-arrestin2-biased characteristics","volume":"7","author":"A Li","year":"2015","journal-title":"Future Med Chem"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/me.2013-1085","article-title":"Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acids","volume":"27","author":"BD Hudson","year":"2013","journal-title":"Molecular endocrinology (Baltimore, Md)"},{"issue":"3\u20134","key":"ref47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prostaglandins.2009.05.003","article-title":"Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis","volume":"89","author":"A Ichimura","year":"2009","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"1\u20132","key":"ref48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mce.2013.01.009","article-title":"Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1","volume":"369","author":"Y Xiong","year":"2013","journal-title":"Molecular and cellular endocrinology"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.2337\/db16-0107","article-title":"Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9\u201339] as a GLP-1 Receptor Antagonist","volume":"65","author":"MA Nauck","year":"2016","journal-title":"Diabetes"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1210\/en.2016-1433","article-title":"Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic alpha-Cell Function and Prevention of Hyperglycemia","volume":"157","author":"R Dusaulcy","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cmet.2017.02.008","article-title":"The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice","volume":"25","author":"AP Chambers","year":"2017","journal-title":"Cell Metab"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T17:04:57Z","timestamp":1589821497000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189060"}},"subtitle":[],"editor":[{"given":"Nigel","family":"Irwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189060","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]}}}